Abstract
Background: The standard of care for most early breast cancer patients is breast conserving surgery (BCS), adjuvant radiotherapy (RT) and systemic therapy. Several trials have confirmed that RT reduces local recurrence, but there are few reports of trials with longterm follow up assessing the impact of omission of RT on overall survival. The Scottish Conservation trial of BCS & systemic therapy appropriate to ER status ± postoperative whole breast RT (Forrest et al. Lancet 1996;348:708–13) showed ipsilateral breast tumour recurrence (IBTR) of 24.5% in the no RT arm and 5.8% in the RT arm but no difference in overall survival at 6 years after randomisation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
